基本信息 |
|
| 产品名称： | 依西美坦中间体 |
| CAS： | 67392-87-4 ;19457-55-7 |
| 中文同义词： | 曲螺酮 ; 屈螺酮 ; 依西美坦中间体 |
| 英文同义词： | ANGELIQ ; DROSPIRENONE ; DROSPERINONE ; 6B,7B:15B,16B-DIMETHYLEN-3-OXO-17A-PREGN-4-ENE-21,17-CARBOLACTONE ; DIHYDROSPIRORENONE ; 6BETA,7BETA,15BETA,16BETA-DIMETHYLENE-3-OXO-17ALPHA-PREGN-4-ENE-21,17-CARBOLACTONE ; DROSPIREONE |
| MDL号： | MFCD00867350 |
| 氢键受体数量： | 3 |
| 氢键供体数量： | 0 |
| Smile： | C[C@]12CCC(=O)C=C1[C@@H]3C[C@@H]3[C@@H]4[C@@H]2CC[C@]5([C@H]4[C@@H]6C[C@@H]6[C@@]57CCC(=O)O7)C |
| InChi： | InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1 |
| InChiKey： | InChIKey=METQSPRSQINEEU-HXCATZOESA-N |
性质 |
|
| 注解： | BIOCHEM/PHYSIOL ACTIONS: DROSPIRENONE IS A FOURTH-GENERATION PROGESTIN THAT HAS ANTIMINERALOCORTICOID, AND ANTIANDROGENIC ACTIVITY IN ADDITION TO POTENT PROGESTOGENIC ACTIVITY. IN TWO RECENT STUDIES DROSPIRENONE APPEARED TO DOUBLE THE RISK OF VENOUS THROMBOEMBOLISM COMPARED TO LEVONORGESTREL, ALTHOUGH OTHER STUDIES FOUND LITTLE ADDED RISK GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA OTHER NOTES: SALES RESTRICTIONS MAY APPLY |
安全信息 |
|
| 符号： |
GHS08
|
| 信号词： | Danger |
| 危险声明： | H360 |
| 警示性声明： | P201-P308 + P313 |
| 危害码： | T |
| 风险声明： | R:60 |
| 安全声明： | S:36/37 |
| WGK德国： | 3 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2025 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1
浙公网安备 33010802004002号
English
